Treatment of cutaneous leiomyomas with 5% lidocaine patches in a patient with hereditary leiomyomatosis and renal cell cancer (Reed syndrome)
Tina Hsu, Lynn A. Cornelius, Ilana S. Rosman, Kathleen M. Nemer
Abstract
Open-access reader
Tina Hsu, Lynn A. Cornelius, Ilana S. Rosman, Kathleen M. Nemer
Abstract
Open-access reader
Hereditary leiomyomatosis and renal cell cancer (HLRCC) (formerly known as Reed syndrome, multiple cutaneous and uterine leiomyomatosis, leiomyomatosis cutis et uteri, and multiple leiomyomatosis) is an autosomal dominant syndrome comprising cutaneous leiomyomas, uterine leiomyomas, or renal tumors. The cutaneous leiomyomas of HLRCC are classically painful and difficult to treat. We report the first case, to our knowledge, of cutaneous leiomyomas symptomatically treated with 5% lidocaine patches.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Hereditary leiomyomatosis and renal cell cancer (HLRCC) (formerly known as Reed syndrome, multiple cutaneous and uterine leiomyomatosis, leiomyomatosis cutis et uteri, and multiple leiomyomatosis) is an autosomal dominant syndrome comprising cutaneous leiomyomas, uterine leiomyomas, or renal tumors. The cutaneous leiomyomas of HLRCC are classically painful and difficult to treat. We report the first case, to our knowledge, of cutaneous leiomyomas symptomatically treated with 5% lidocaine patches.
Key concepts: Leiomyomatosis, Medicine, Leiomyoma, Uterine leiomyoma, Pathology